Evidence map›Paper›PMID 29409307›Full record

ArticleGut and liver2018

Prevalence and Implications of Bone Marrow Involvement in Patients with Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.

Sang Il Choi, Myeong-Cherl Kook, Sanghyun Hwang, Young-Il Kim, Jong Yeul Lee, Chan Gyoo Kim, Il Ju Choi, Hyewon Lee, Hyeon Seok Eom, Soo-Jeong Cho

Open access · diamondAbstract readMulticenter Study
In one paragraph

Article in Gut and liver, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. [Characteristics of Gastric Mucosa-associated Lymphoid Tissue Lymphoma in Korea].The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2024
    Review
  4. [Long Term Clinical Outcomes of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma: A Single Center Study].The Korean journal of helicobacter and upper gastrointestinal research · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Sang Il ChoiCenter for Gastric Cancer, National Cancer Center, Goyang, Korea.
Myeong-Cherl KookCenter for Gastric Cancer, National Cancer Center, Goyang, Korea.
Sanghyun HwangDepartment of Laboratory Medicine, Asan Medical Center, Seoul, Korea.
Young-Il KimCenter for Gastric Cancer, National Cancer Center, Goyang, Korea.
Jong Yeul LeeCenter for Gastric Cancer, National Cancer Center, Goyang, Korea.
Chan Gyoo KimCenter for Gastric Cancer, National Cancer Center, Goyang, Korea.
Il Ju ChoiCenter for Gastric Cancer, National Cancer Center, Goyang, Korea.
Hyewon LeeCenter for Hematologic Malignancy, National Cancer Center, Goyang, Korea.
Hyeon Seok EomCenter for Hematologic Malignancy, National Cancer Center, Goyang, Korea.
Soo-Jeong ChoCenter for Gastric Cancer, National Cancer Center, Goyang, Korea.
National Cancer Center · KRAsan Medical Center · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimsMucosa-associated lymphoid tissue (MALT) lymphoma of the stomach is an uncommon disease. Bone marrow involvement is reported even in patients with only a mucosal lesion. We evaluated the prevalence and risk factors of marrow involvement and its implications for diagnosis and treatment.

methodsIn total, 132 patients who were diagnosed with gastric MALT lymphoma at the National Cancer Center in Korea between January 2001 and December 2016 were enrolled in the study. The patient data were collected and analyzed retrospectively.

resultsOf the 132 patients, 47 (35.6%) were male, with a median age of 52 years (range, 17 to 81 years). The median follow-up duration was 48.8 months (range, 0.5 to 169.9 months).

conclusionsBone marrow involvement was found in 4.3% of the patients with gastric MALT lymphoma. Bone marrow examination may be deferred because marrow involvement does not change the treatment options or outcome in gastric MALT lymphoma confined to the stomach wall.

Indexed as

AdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsBiopsy, NeedleBone MarrowBone Marrow NeoplasmsDrug Therapy, CombinationEndoscopyFemaleGastric MucosaHelicobacter InfectionsHumansLymphoma, B-Cell, Marginal ZoneMaleAnti-Bacterial AgentsProton Pump InhibitorsBone marrow involvementHelicobacter pyloriLymphoma, B-cell, marginal zonePrognosis

Identifiers

PMID29409307
PMCPMC5945259
OpenAlexW2792965190

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.